Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis

T-Reuters2021-08-30

Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（12）

JoelLee
·2021-08-31
Reply and comment pls thx!
Reply
1
Report
Fold Replies
- JoelLee:
  Jsjsjsjsjsjllele
  2021-08-31
  Reply
  Report
KhunSao
·2021-08-31
?
Reply
1
Report
sickeninglim
·2021-08-31
Wow....
Reply
2
Report
Fold Replies
- junan:
  Yes
  2021-08-31
  Reply
  Report
Heng08
·2021-08-31
Good
Reply
3
Report
Fold Replies
- Mml:
  Yup
  2021-08-31
  Reply
  Report
cynn
·2021-08-31
Great
Reply
2
Report
HENRYCSC
·2021-08-30
Good
Reply
1
Report
Horsesaylah
·2021-08-30
Not time yet
Reply
2
Report
Fold Replies
- Phyusin:
  When?
  2021-08-31
  Reply
  Report
ALearner
·2021-08-30
Pfizer !
Reply
1
Report
Chongshen
·2021-08-30
Pfizer is still going down despite many positive news last week
Reply
8
Report
Fold Replies
- Phyusin:
  Yes why?
  2021-08-31
  Reply
  Report
- Tunaaa:
  Ya why!
  2021-08-30
  Reply
  Report
PhilipGoh
·2021-08-30
Good ????
Reply
3
Report
nctony
·2021-08-30
Great news,up up up[財迷]
Reply
4
Report
Fold Replies
- Phyusin:
  Now down
  2021-08-31
  Reply
  Report
- Mml:
  Yup
  2021-08-30
  Reply
  Report
jovansim
·2021-08-30
godlike
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2163888743?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-30 18:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2163888743","market":"us","top_or_hot":-1,"title":"Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis","media":"T-Reuters","content":"<html><body><p>Pfizer Inc <pfe.n>:Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.</pfe.n></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPositive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-30 18:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.trkd.thomsonreuters.com><strong>T-Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial ...</p>\n\n<a href=\"https://www.trkd.thomsonreuters.com\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2163888743","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2163888743","pubTimestamp":1630320528,"sourceInfo":null,"weMediaInfo":{"media_name":"T-Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy O","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","LHDX":"Lucira Health, Inc.","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc.","LABP":"Landos Biopharma, Inc.","CGEM":"Cullinan Therapeutics"},"translate_title":"辉瑞3期Jade Dare试验的阳性顶线结果比较阿布替尼和杜匹卢单抗治疗中重度特应性皮炎的疗效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9,"APR":0.86,"CGEM":0.86,"LABP":0.86,"LHDX":0.86,"SANA":0.86},"content_text":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":818641236,"gmtCreate":1630407165525,"gmtModify":1676530294322,"author":{"id":"3579882572140125","authorId":"3579882572140125","name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":1,"crmLevelSwitch":1,"idStr":"3579882572140125","authorIdStr":"3579882572140125"},"htmlText":"Reply and comment pls thx!","listText":"Reply and comment pls thx!","text":"Reply and comment pls thx!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818641236","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5705320,"gmtCreate":1630407184935,"gmtModify":1663233169142,"authorId":3579882572140125,"author":{"id":3579882572140125,"idStr":"3579882572140125","authorId":3579882572140125,"name":"JoelLee","avatar":"https://static.tigerbbs.com/e1f6c92b13d94cba61906c07dbbb2ab6","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.08","exceedPercentage":"80.77%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":1,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":818641236,"type":1,"supId":0,"prevId":0,"content":"Jsjsjsjsjsjllele","text":"Jsjsjsjsjsjllele","html":"Jsjsjsjsjsjllele"}],"langContent":"EN"},{"id":818694644,"gmtCreate":1630400920088,"gmtModify":1676530292564,"author":{"id":"3586405989757525","authorId":"3586405989757525","name":"KhunSao","avatar":"https://static.tigerbbs.com/91ff42b55eed52cbbe5e0c6323d0e1d7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586405989757525","authorIdStr":"3586405989757525"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818694644","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":818908601,"gmtCreate":1630368868003,"gmtModify":1676530281391,"author":{"id":"3575453671192179","authorId":"3575453671192179","name":"sickeninglim","avatar":"https://static.tigerbbs.com/0753a2906468fc16c39e5f831b2200d7","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":1,"idStr":"3575453671192179","authorIdStr":"3575453671192179"},"htmlText":"Wow....","listText":"Wow....","text":"Wow....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818908601","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5699801,"gmtCreate":1630369527051,"gmtModify":1635135247140,"authorId":4087454422417330,"author":{"id":4087454422417330,"idStr":"4087454422417330","authorId":4087454422417330,"name":"junan","avatar":"https://static.tigerbbs.com/01c6bbe9bc1c46918924830458fea61c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":818908601,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":811789290,"gmtCreate":1630352555310,"gmtModify":1676530277238,"author":{"id":"4088201880010570","authorId":"4088201880010570","name":"Heng08","avatar":"https://community-static.tradeup.com/news/505153f04c3a6654891a2cb833a63f89","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"4088201880010570","authorIdStr":"4088201880010570"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/811789290","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5698516,"gmtCreate":1630364717946,"gmtModify":1663233136535,"authorId":3584863771682470,"author":{"id":3584863771682470,"idStr":"3584863771682470","authorId":3584863771682470,"name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811789290,"type":1,"supId":0,"prevId":0,"content":"Yup","text":"Yup","html":"Yup"}],"langContent":"EN"},{"id":811795770,"gmtCreate":1630344269590,"gmtModify":1676530276664,"author":{"id":"4091975549439940","authorId":"4091975549439940","name":"cynn","avatar":"https://static.tigerbbs.com/d45b68148695cb02b6620353f88f7880","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4091975549439940","authorIdStr":"4091975549439940"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811795770","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":811513111,"gmtCreate":1630331710833,"gmtModify":1676530271889,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811513111","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":811536458,"gmtCreate":1630331431374,"gmtModify":1676530271637,"author":{"id":"3570240810344953","authorId":"3570240810344953","name":"Horsesaylah","avatar":"https://static.tigerbbs.com/7a32990d23360f1c603728cf63a7ec50","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":2,"crmLevelSwitch":0,"idStr":"3570240810344953","authorIdStr":"3570240810344953"},"htmlText":"Not time yet","listText":"Not time yet","text":"Not time yet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/811536458","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5698604,"gmtCreate":1630365138519,"gmtModify":1663233136639,"authorId":3584490239949882,"author":{"id":3584490239949882,"idStr":"3584490239949882","authorId":3584490239949882,"name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811536458,"type":1,"supId":0,"prevId":0,"content":"When?","text":"When?","html":"When?"}],"langContent":"EN"},{"id":811267638,"gmtCreate":1630327902824,"gmtModify":1676530269858,"author":{"id":"3581627611317712","authorId":"3581627611317712","name":"ALearner","avatar":"https://static.tigerbbs.com/dd4e09038044887c08337f0d263b9446","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3581627611317712","authorIdStr":"3581627611317712"},"htmlText":"Pfizer !&nbsp;","listText":"Pfizer !&nbsp;","text":"Pfizer !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811267638","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":811297612,"gmtCreate":1630325153336,"gmtModify":1676530268707,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"htmlText":"Pfizer is still going down despite many positive news last week","listText":"Pfizer is still going down despite many positive news last week","text":"Pfizer is still going down despite many positive news last week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811297612","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5698609,"gmtCreate":1630365148299,"gmtModify":1663233139133,"authorId":3584490239949882,"author":{"id":3584490239949882,"idStr":"3584490239949882","authorId":3584490239949882,"name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811297612,"type":1,"supId":0,"prevId":0,"content":"Yes why?","text":"Yes why?","html":"Yes why?"},{"id":5694437,"gmtCreate":1630326632635,"gmtModify":1663233115952,"authorId":3586991451337808,"author":{"id":3586991451337808,"idStr":"3586991451337808","authorId":3586991451337808,"name":"Tunaaa","avatar":"https://static.tigerbbs.com/ce153d45d93b437fb6713a9e09b459b7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811297612,"type":1,"supId":0,"prevId":0,"content":"Ya why!","text":"Ya why!","html":"Ya why!"}],"langContent":"EN"},{"id":811671813,"gmtCreate":1630322448932,"gmtModify":1676530268049,"author":{"id":"3574730309796268","authorId":"3574730309796268","name":"PhilipGoh","avatar":"https://static.tigerbbs.com/d6085185a57dcb9a222e871338387428","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":7,"crmLevelSwitch":1,"idStr":"3574730309796268","authorIdStr":"3574730309796268"},"htmlText":"Good ????","listText":"Good ????","text":"Good ????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811671813","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":811647622,"gmtCreate":1630322003466,"gmtModify":1676530267961,"author":{"id":"3557024931927052","authorId":"3557024931927052","name":"nctony","avatar":"https://static.tigerbbs.com/1449dfc5089ded0e8efe303fd4dd43b1","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3557024931927052","authorIdStr":"3557024931927052"},"htmlText":"Great news,up up up[財迷]&nbsp;","listText":"Great news,up up up[財迷]&nbsp;","text":"Great news,up up up[財迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811647622","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5698612,"gmtCreate":1630365158637,"gmtModify":1663233139740,"authorId":3584490239949882,"author":{"id":3584490239949882,"idStr":"3584490239949882","authorId":3584490239949882,"name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811647622,"type":1,"supId":0,"prevId":0,"content":"Now down","text":"Now down","html":"Now down"},{"id":5694460,"gmtCreate":1630326815184,"gmtModify":1663233118132,"authorId":3584863771682470,"author":{"id":3584863771682470,"idStr":"3584863771682470","authorId":3584863771682470,"name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":811647622,"type":1,"supId":0,"prevId":0,"content":"Yup","text":"Yup","html":"Yup"}],"langContent":"CN"},{"id":811646489,"gmtCreate":1630321664841,"gmtModify":1676530267860,"author":{"id":"3584526700310105","authorId":"3584526700310105","name":"jovansim","avatar":"https://static.tigerbbs.com/0f3c300491805f20e8643c565850e7bb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584526700310105","authorIdStr":"3584526700310105"},"htmlText":"godlike","listText":"godlike","text":"godlike","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/811646489","repostId":2163888743,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":81,"commentSize":12,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}